4[1]Albain KS, Pass HI. Induction therapy before surgery for non-small cell lung cancer. Lung Cancer,2000,29(Suppl 2)∶168-171.
5[2]Saito Y, Minami K, Kobayashi M, et al. Ten year's experience of induction therapy for locally advanced NSCLC: a single institute study. Lung Cancer,2000,29(Suppl 1)∶89.
6[3]De Pierre A, Milleron B, Chevret S, et al. French phase Ⅲ trial of preoperative chemotherapy (PCT) in resectable stage Ⅰ( except T1N0), Ⅱ,ⅢA non-small cell lung cancer (NSCLC). Lung Cancer,2000,29(Suppl 1)∶91.
7[4]Pitz C, Riviere BDI, Beek FV, et al. Phase Ⅱ study of induction chemotherapy in patients with stage ⅢB NSCLC. Lung Cancer, 2000,29(Suppl 1)∶89.
8[5]Abolhoda A, Martin J, Ginsberg RJ, et al. Morbidity and mortality for pulmonary resections in lung cancer after induction treatment. Lung Cancer,2000,29(Suppl 1)∶89.
9[6]Mattson K, Velde T, Krofta K, et al. Early results of an international phase Ⅲ study evaluating Taxotere as neoadjuvant therapy for radically-treatable stage Ⅲ NSCLC. Lung Cancer,2000,29(Suppl 1)∶90.
10[7]Kim J, Shim YM, Kim K, et al. A Phase Ⅱ trial of preoperative concurrent chemoradiotherapy for stage ⅢA non-small cell lung cancer with mediastinal lymph node involvement. Lung Cancer, 2000,29(Suppl 1)∶91.
